// App-Quantinova.ai

: Pomalidomide and Dexamethasone Grant Rapid Hematologic Responses in Patients with Relapsed and Refractory AL Amyloidois: A European Retrospective Series of 150 Patients

Researchers

Presenter

  • Paolo Milani

Principal Investigators

  • Faye Sharpley

  • Stefan Schnland

  • Marco Basset

  • Shameem Mahmood

  • Christoph Kimmich

  • Andrea Foli

  • Sajitha Sachchithanantham

  • Giampaolo Merlini

  • Ashutosh D. Wechalekar

  • Giovanni Palladini

  • Ute Hegenbart

Medical Centers

  • Amyloidosis Research and Treatment Center, Department of Molecular Medicine, Foundation IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy

  • National Amyloidosis Centre, University College London, London, United Kingdom

  • Medizinische Klinik V and Amyloidosis Center, Universitätsklinikum Heidelberg, Heidelberg, Germany

  • Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy

  • Haematology, University College London Hospitals NHS Foundation Trust (UCLH), London, United Kingdom

  • Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy

Locations

  • Italy

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • AL Amyloidosis

  • Gastric antral vascular ectasia

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Pomalidomide

  • CC-4047

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved